Risk factors for developing triple-negative breast cancer
Breast cancer is the most common cancer in women. Among the 1.67 million women diagnosed each year, 15% are diagnosed with triple-negative breast cancer (TNBC). More common in women under the age of 50, TNBC has limited treatment options and is associated with particularly poor survival rates. Knowing the signs and symptoms of breast cancer is essential for early diagnosis and treatment.
For more information on TNBC, visit https://www.roche.com/dam/jcr:83655b8...
Subscribe to our YouTube channel now: https://www.youtube.com/user/roche?sub_confirmation=1
Get in touch with us:
https://www.roche.com/
https://www.facebook.com/RocheCareers
https://www.linkedin.com/company/roche
https://twitter.com/roche
Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.
For more information and insights visit: https://www.roche.com/
Видео Risk factors for developing triple-negative breast cancer канала Roche
For more information on TNBC, visit https://www.roche.com/dam/jcr:83655b8...
Subscribe to our YouTube channel now: https://www.youtube.com/user/roche?sub_confirmation=1
Get in touch with us:
https://www.roche.com/
https://www.facebook.com/RocheCareers
https://www.linkedin.com/company/roche
https://twitter.com/roche
Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.
For more information and insights visit: https://www.roche.com/
Видео Risk factors for developing triple-negative breast cancer канала Roche
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Alex's story of breast cancerElevated INR valuesRoche Diagnostics Pakistan - COVID-19 ResponseRoche Latin America: Committed to improving access to healthcare in the regionMeet our Patient Journey Partner | Roche TaiwanЧИ ПІДХОДИТЬ МЕНІ ЦЕ КЛІНІЧНЕ ДОСЛІДЖЕННЯ?¿Es un estudio de investigación clínica adecuado para mí?Jamali luguUnited against the cancer care gapFUMO - Saying YES to further researchStart Patient Safety - Our first months at RochePatient Perspectives | Surviving Placenta AccretaAbout pulmonary fibrosis in 90 seconds (Lithuanian version)Step into the Future with Roche Services & Solutions in LatviaRoche 2019 | Performance HighlightsDuurzame relaties maken een fundamenteel verschilOur job: to really make a differenceStaying active despite progression | Anat’s storyĐể Cổ tử cung lên tiếngA patient’s perspectiveRoche PIA | MindAffect